MDB Capital Holdings, LLC Class A (MDBH)
NASDAQ:MDBH
Want to see MDBH full AI Analyst Report?
Earnings Data
Report Date
May 27, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
―Last Year’s EPS
-0.66Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call emphasized significant operational progress and strategic positioning (notably rapid AI-driven diligence improvements, building two discrete monetizable assets in MDB Direct and PatentVest, a clearer path to lower run-rate OpEx, and a sizable pipeline with several assets that management believes have $1B potential). However, the company faces material near-term challenges: a prolonged public stock decline, difficult microcap market conditions, a critical distribution gap needed to scale launches, execution issues at some portfolio companies, and ongoing financing/valuation uncertainty for spinouts. The tone is optimistic about future scalability but pragmatic about the risks and uncertainty in execution and market reception.Company Guidance
AI-Driven Diligence Acceleration
Management reports AI reduced diligence inertia dramatically: they estimate compressing time-to-answer by ~2/3 (≈66.7%). Patentability analyses that previously took ~45 hours are now done in ~1.5 hours (≈96.7% faster). S-1 preparation that historically took 6–18 months is expected to be achievable in weeks, enabling far faster company launches.
Strategic Asset Build: MDB Direct (clearing) and PatentVest
Company invested roughly $4.0M annually (since the IPO) into MDB Direct and PatentVest to build them as discrete assets. MDB Direct (self-clearing capability) is operational and management is in active strategic-partner discussions; comparable clearing firms have sold for 'tens of millions.' PatentVest is operating as an ABS IP law firm, with the U.S. patent prosecution market sized at an estimated $10–15B opportunity. Both assets are planned to be financed as independent entities and pursued for monetization/spinout.
Improved Financial Leverage and Lower Run-Rate Post-Spinouts
Reported year-end net cash/current assets (cash + marketable securities less current liabilities) of approximately $22.3M. Annual fixed operating expenses are about $10M; reported cash burn for the year was $5.7M. Management states the $4M invested in clearing/PatentVest is part of that OpEx — excluding that would imply a $1.7M net burn. After spinning out the clearing platform and PatentVest, OpEx is expected to fall to about $6M annually, improving leverage as the firm scales launches.
Pipeline Scalability and Portfolio Upside
Management reiterates the target to scale to 3–5 company launches per year. Principal portfolio assets highlighted with large upside: eXoZymes (year-end market value ~ $45M; current holding ~ $30M), Paulex (7.1M shares owned; IPO planned later this year and clinical trial initiation targeted for September), and other co-founded assets with perceived $1B upside potential. Management emphasizes capital efficiency for certain portfolio companies, notably eXoZymes, which they expect will require relatively modest dilution due to grant funding and outsourced manufacturing.
Operational and Clinical Progress Across Portfolio
Notable operational milestones: HeartBeam received FDA clearance for its ambulatory 12-lead ECG device (positioned as highly sensitive and partnership-worthy); Cue Biopharma has partnerships (Boehringer Ingelheim, ImmunoScape) and is preparing a 401 study; eXoZymes has progressed technologies to contract manufacturers demonstrating scalable biomanufacturing; Buda (fresh-juice chain) is profitable and positioned for retail expansion.
MDB Capital Holdings, LLC Class A (MDBH) Earnings, Revenues Date & History
MDBH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
MDBH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 31, 2026 | $2.98 | $3.19 | +7.05% |
Nov 20, 2025 | $3.38 | $3.26 | -3.55% |
Aug 27, 2025 | $3.45 | $3.50 | +1.45% |
May 21, 2025 | $4.76 | $4.70 | -1.26% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does MDB Capital Holdings, LLC Class A (MDBH) report earnings?
MDB Capital Holdings, LLC Class A (MDBH) is schdueled to report earning on May 27, 2026, After Close (Confirmed).
What is MDB Capital Holdings, LLC Class A (MDBH) earnings time?
MDB Capital Holdings, LLC Class A (MDBH) earnings time is at May 27, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MDBH EPS forecast?
Currently, no data Available